Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts

Journal of Clinical Microbiology

Volumn 35, Issue 11, 1997, Pages 2878-2882

  Clancy, Cornelius J ^a   Nguyen, M Hong ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FLUCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CANDIDA; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC PROCEDURE; FUNGUS GROWTH; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; OPTICAL DENSITY; PHOTOMETRY; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); CANDIDA; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0030813019     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.11.2878-2882.1997     Document Type: Article

References (19)

1. Barchiesi, F., A. I. Colombo, D. A. McGough, and M. G. Rinaldi. 1994. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. J. Clin. Microbiol. 32:2494-2500.
2. Barchiesi, F., M. Del Poeta, V. Morbiducci, F. Ancarani, and G. Scalise. 1993. Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans. Mycopathologia 124:19-25.
3. Espinel-Ingroff, A., C. W. Kish, T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.
4. Espinel-Ingroff, A., J. L. Rodriguez-Tudela, and J. V. Martinez-Suarez. 1995. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 33:3154-3158.
5. Espinel-Ingroff, A., T. M. Kerkering, P. R. Goldson, and S. Shadomy. 1991. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 29:1089-1094.
6. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
7. Jahn, B., E. Martin, A. Stueben, and S. Bhakdi. 1995. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl 2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J. Clin. Microb. 33:661-667.
8. Meshulam T., S. M. Levitz, L. Christin, and R. D. Diamond. 1995. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanilide (XTT). J. Infect. Dis. 172:1153-1156.
9. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. Nguyen, M. H., J. E. Peacock, Jr., A. J. Morris, et al. 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100:617-623.
11. Pfaller, M. A., and M. G. Rinaldi. 1993. Antifungal susceptibility testing: current status of technology, limitations, and standardization. Infect. Dis. Clin. N. Am. 7:435-444.
12. Pfaller, M. A., and A. L. Berry. 1994. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1992-1996.
13. Rex, J. H., M. A. Pfaller, J. N. Galgiani, et al. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
14. Scudiero, D. A., R. H. Shoemaker, K. D. Paull, et al. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827-4833.
15. Tellier, R., M. Krajden, G. A. Grigoriew, and I. Campbell. 1992. Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob. Agents Chemother. 36:1619-1625.
16. Tiballi, R. N., X. He, L. T. Zarins, S. G. Revankar, and C. A. Kauffman. 1995. Use of a colorimetric system for yeast susceptibility testing. J. Clin. Microbiol. 33:915-917.
17. Tiballi, R. N., L. T. Zarins, X. He, and C. A. Kauffman. 1995. Torulopsis glabrata: Azole susceptibilities by microdilution colorimetric and macrodilution broth assays. J. Clin. Microbiol. 33:2612-2615.
18. To, W., A. W. Fothergill, and M. G. Rinaldi. 1995. Comparative evaluation of macrodilution and Alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 33:2660-2664.
19. Van der Auwera, P., A. M. Ceuppens, C. Heymans, and F. Meunier. 1986. In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations. Antimicrob. Agents Chemother. 29:997-1004.